Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Zhenzhu Tiaozhi Capsules in NAFLD
NCT03375580Unknown
- Sponsor
- The First Affiliated Hospital of Guangdong Pharmaceutical University
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Compound Zhenzhu Tiaozhi in non-alcoholic fatty liver disease (NAFLD) (4 arms), sponsored by The First Affiliated Hospital of Guangdong Pharmaceutical University. Primary endpoint: Fat attenuation index at 6 months. Status: unknown.
02
Drugs
Compound Zhenzhu Tiaozhi
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03375580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375580.